CMS faces renewed legal pressure on drug price negotiation program
Teva Pharmaceuticals is suing the Centers for Medicare & Medicaid Services (CMS) for its implementation of the drug price negotiation program under the Inflation Reduction Act (IRA). | A new lawsuit from a drug manufacturer, this time by Teva Pharmaceuticals, is challenging CMS on the Inflation Reduction Act’s drug price negotiation program.